Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016

Date: October 20, 2016
Pages: 141
Price:
US$ 995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PC17C247C3EEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016
SUMMARY

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
SYNOPSIS

Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

REASONS TO BUY
  • What was the size of the emerging five pharmaceuticals market by value in 2015?
  • What will be the size of the emerging five pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?
KEY HIGHLIGHTS
  • These countries contributed $149.8 billion to the global pharmaceuticals industry in 2015, with a compound annual growth rate (CAGR) of 12.7% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $235.3 billion in 2020, with a CAGR of 9.4% over the 2015-20 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $97.9 billion in 2015. This was followed by India and Brazil with a value of $26.8 and $13.9 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $145.4 billion in 2020, followed by India and Brazil with expected values of $57.5 and $19.2 billion, respectively.
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Top Emerging Countries Pharmaceuticals
Industry Outlook
China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $. billion in , followed by India and Brazil with expected values of $. and $. billion, respectively.
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2011-20
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2011-15
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2015-20
Table 4: South Africa pharmaceuticals market value: $ billion, 2011-15
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2015
Table 6: South Africa pharmaceuticals market share: % share, by value, 2015
Table 7: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
Table 8: Adcock Ingram Holdings Limited: key facts
Table 9: Adcock Ingram Holdings Limited: key financials ($)
Table 10: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 11: Adcock Ingram Holdings Limited: key financial ratios
Table 12: Aspen Pharmacare Holdings Ltd: key facts
Table 13: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 14: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 15: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 16: Novartis AG: key facts
Table 17: Novartis AG: key financials ($)
Table 18: Novartis AG: key financial ratios
Table 19: Sanofi SA: key facts
Table 20: Sanofi SA: key financials ($)
Table 21: Sanofi SA: key financials (€)
Table 22: Sanofi SA: key financial ratios
Table 23: South Africa size of population (million), 2011-15
Table 24: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 25: South Africa gdp (current prices, $ billion), 2011-15
Table 26: South Africa inflation, 2011-15
Table 27: South Africa consumer price index (absolute), 2011-15
Table 28: South Africa exchange rate, 2011-15
Table 29: Brazil pharmaceuticals market value: $ billion, 2011-15
Table 30: Brazil pharmaceuticals market geography segmentation: $ billion, 2015
Table 31: Brazil pharmaceuticals market share: % share, by value, 2015
Table 32: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
Table 33: Aché Laboratórios Farmacêuticos S.A.: key facts
Table 34: EMS Sigma Pharma: key facts
Table 35: Sanofi SA: key facts
Table 36: Sanofi SA: key financials ($)
Table 37: Sanofi SA: key financials (€)
Table 38: Sanofi SA: key financial ratios
Table 39: Brazil size of population (million), 2011-15
Table 40: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 41: Brazil gdp (current prices, $ billion), 2011-15
Table 42: Brazil inflation, 2011-15
Table 43: Brazil consumer price index (absolute), 2011-15
Table 44: Brazil exchange rate, 2011-15
Table 45: China pharmaceuticals market value: $ billion, 2011-15
Table 46: China pharmaceuticals market geography segmentation: $ billion, 2015
Table 47: China pharmaceuticals market share: % share, by value, 2015
Table 48: China pharmaceuticals market value forecast: $ billion, 2015-20
Table 49: Guangzhou Pharmaceutical Holdings Limited: key facts
Table 50: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 51: Yangtze River Pharmaceutical Group: key facts
Table 52: Yunnan Baiyao Group Co., Ltd.: key facts
Table 53: Yunnan Baiyao Group Co., Ltd.: key financials ($)
Table 54: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
Table 55: Yunnan Baiyao Group Co., Ltd.: key financial ratios
Table 56: China size of population (million), 2011-15
Table 57: China gdp (constant 2005 prices, $ billion), 2011-15
Table 58: China gdp (current prices, $ billion), 2011-15
Table 59: China inflation, 2011-15
Table 60: China consumer price index (absolute), 2011-15
Table 61: China exchange rate, 2011-15
Table 62: India pharmaceuticals market value: $ billion, 2011-15
Table 63: India pharmaceuticals market geography segmentation: $ billion, 2015
Table 64: India pharmaceuticals market share: % share, by value, 2015
Table 65: India pharmaceuticals market value forecast: $ billion, 2015-20
Table 66: Aurobindo Pharma Limited: key facts
Table 67: Aurobindo Pharma Limited: key financials ($)
Table 68: Aurobindo Pharma Limited: key financials (Rs.)
Table 69: Aurobindo Pharma Limited: key financial ratios
Table 70: Lupin Limited: key facts
Table 71: Lupin Limited: key financials ($)
Table 72: Lupin Limited: key financials (Rs.)
Table 73: Lupin Limited: key financial ratios
Table 74: Dr. Reddy's Laboratories Limited: key facts
Table 75: Dr. Reddy's Laboratories Limited: key financials ($)
Table 76: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 77: Dr. Reddy's Laboratories Limited: key financial ratios
Table 78: Sun Pharmaceutical Industries Ltd.: key facts
Table 79: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 80: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 81: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 82: India size of population (million), 2011-15
Table 83: India gdp (constant 2005 prices, $ billion), 2011-15
Table 84: India gdp (current prices, $ billion), 2011-15
Table 85: India inflation, 2011-15
Table 86: India consumer price index (absolute), 2011-15
Table 87: India exchange rate, 2011-15
Table 88: Mexico pharmaceuticals market value: $ billion, 2011-15
Table 89: Mexico pharmaceuticals market geography segmentation: $ billion, 2015
Table 90: Mexico pharmaceuticals market share: % share, by value, 2015
Table 91: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Table 92: Bayer AG: key facts
Table 93: Bayer AG: key financials ($)
Table 94: Bayer AG: key financials (€)
Table 95: Bayer AG: key financial ratios
Table 96: Merck and Co., Inc.: key facts
Table 97: Merck and Co., Inc.: key financials ($)
Table 98: Merck and Co., Inc.: key financial ratios
Table 99: Novartis AG: key facts
Table 100: Novartis AG: key financials ($)
Table 101: Novartis AG: key financial ratios
Table 102: Pfizer Inc.: key facts
Table 103: Pfizer Inc.: key financials ($)
Table 104: Pfizer Inc.: key financial ratios
Table 105: Mexico size of population (million), 2011-15
Table 106: Mexico gdp (constant 2005 prices, $ billion), 2011-15
Table 107: Mexico gdp (current prices, $ billion), 2011-15
Table 108: Mexico inflation, 2011-15
Table 109: Mexico consumer price index (absolute), 2011-15
Table 110: Mexico exchange rate, 2011-15

LIST OF FIGURES

Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2011-20
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2011-15
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2015-20
Figure 4: South Africa pharmaceuticals market value: $ billion, 2011-15
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 6: South Africa pharmaceuticals market share: % share, by value, 2015
Figure 7: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2015
Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2015
Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2015
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2015
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2015
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2015
Figure 14: Adcock Ingram Holdings Limited: revenues and profitability
Figure 15: Adcock Ingram Holdings Limited: assets and liabilities
Figure 16: Aspen Pharmacare Holdings Ltd: revenues and profitability
Figure 17: Aspen Pharmacare Holdings Ltd: assets and liabilities
Figure 18: Novartis AG: revenues and profitability
Figure 19: Novartis AG: assets and liabilities
Figure 20: Sanofi SA: revenues and profitability
Figure 21: Sanofi SA: assets and liabilities
Figure 22: Brazil pharmaceuticals market value: $ billion, 2011-15
Figure 23: Brazil pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 24: Brazil pharmaceuticals market share: % share, by value, 2015
Figure 25: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
Figure 26: Forces driving competition in the pharmaceuticals market in Brazil, 2015
Figure 27: Drivers of buyer power in the pharmaceuticals market in Brazil, 2015
Figure 28: Drivers of supplier power in the pharmaceuticals market in Brazil, 2015
Figure 29: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2015
Figure 30: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2015
Figure 31: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2015
Figure 32: Sanofi SA: revenues and profitability
Figure 33: Sanofi SA: assets and liabilities
Figure 34: China pharmaceuticals market value: $ billion, 2011-15
Figure 35: China pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 36: China pharmaceuticals market share: % share, by value, 2015
Figure 37: China pharmaceuticals market value forecast: $ billion, 2015-20
Figure 38: Forces driving competition in the pharmaceuticals market in China, 2015
Figure 39: Drivers of buyer power in the pharmaceuticals market in China, 2015
Figure 40: Drivers of supplier power in the pharmaceuticals market in China, 2015
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2015
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2015
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in China, 2015
Figure 44: Yunnan Baiyao Group Co., Ltd.: revenues and profitability
Figure 45: Yunnan Baiyao Group Co., Ltd.: assets and liabilities
Figure 46: India pharmaceuticals market value: $ billion, 2011-15
Figure 47: India pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 48: India pharmaceuticals market share: % share, by value, 2015
Figure 49: India pharmaceuticals market value forecast: $ billion, 2015-20
Figure 50: Forces driving competition in the pharmaceuticals market in India, 2015
Figure 51: Drivers of buyer power in the pharmaceuticals market in India, 2015
Figure 52: Drivers of supplier power in the pharmaceuticals market in India, 2015
Figure 53: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2015
Figure 54: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2015
Figure 55: Drivers of degree of rivalry in the pharmaceuticals market in India, 2015
Figure 56: Aurobindo Pharma Limited: revenues and profitability
Figure 57: Aurobindo Pharma Limited: assets and liabilities
Figure 58: Lupin Limited: revenues and profitability
Figure 59: Lupin Limited: assets and liabilities
Figure 60: Dr. Reddy's Laboratories Limited: revenues and profitability
Figure 61: Dr. Reddy's Laboratories Limited: assets and liabilities
Figure 62: Sun Pharmaceutical Industries Ltd.: revenues and profitability
Figure 63: Sun Pharmaceutical Industries Ltd.: assets and liabilities
Figure 64: Mexico pharmaceuticals market value: $ billion, 2011-15
Figure 65: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 66: Mexico pharmaceuticals market share: % share, by value, 2015
Figure 67: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
Figure 68: Forces driving competition in the pharmaceuticals market in Mexico, 2015
Figure 69: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015
Figure 70: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015
Figure 71: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015
Figure 72: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015
Figure 73: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015
Figure 74: Bayer AG: revenues and profitability
Figure 75: Bayer AG: assets and liabilities
Figure 76: Merck and Co., Inc.: revenues and profitability
Figure 77: Merck and Co., Inc.: assets and liabilities
Figure 78: Novartis AG: revenues and profitability
Figure 79: Novartis AG: assets and liabilities
Figure 80: Pfizer Inc.: revenues and profitability
Figure 81: Pfizer Inc.: assets and liabilities
Skip to top


Haircare Top 5 Emerging Markets Industry Guide 2016 US$ 995.00 Jul, 2016 · 133 pages
New Cars Top 5 Emerging Markets Industry Guide 2016 US$ 995.00 Jul, 2016 · 134 pages
Airlines Top 5 Emerging Markets Industry Guide_2016 US$ 995.00 Oct, 2016 · 142 pages

Ask Your Question

Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: